The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope

References

1. Baboonian C., Blake K., Booth J. C., Wiblin C. N. 1989; Complement-independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus. Journal of Medical Virology 29:139–145
   [Google Scholar]
2. Bowden R. A., Sayers M., Flournoy N. 1986; Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after bone marrow transplantation. New England Journal of Medicine 314:1006–1010
   [Google Scholar]
3. Britt W. J. 1984; Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
   [Google Scholar]
4. Britt W. J., Auger D. 1986; Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. Journal of Virology 61:185–191
   [Google Scholar]
5. Britt W. J., Vugler L. G. 1989; Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. Journal of Virology 63:403–410
   [Google Scholar]
6. Britt W. J., Vugler L., Stephens E. B. 1988; Induction of complement dependent and independent neutralizing antibodies by recombinant derived human cytomegalovirus gp55-116 (gB). Journal of Virology 62:3309–3318
   [Google Scholar]
7. Britt W. J., Vugler L., Butfiloski E. S., Stephans E. B. 1990a; Cell surface expression of human cytomegalovirus (HCMV) gp55- 116(gB): use of HCMV-vaccinia recombinant virus infected cells in analysis of the human neutralizing antibody response. Journal of Virology in press
   [Google Scholar]
8. Britt W. J., Fay J., Stephens E., Kniess N., Utz U., Mach M. 1990b; Identification of an immunodominant linear epitope on human cytomegalovirus gp55/116 (gB). In Vaccines ′90 New York: Cold Spring Harbor Laboratory; in press
   [Google Scholar]
9. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson S. E., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
   [Google Scholar]
10. Edson C. M., Hosler B. A., Waters D. J. 1987; Varicella zoster virus gpl and herpes simplex virus gE: phosphorylation and Fc binding. Virology 161:509–602
    [Google Scholar]
11. Gabel C. A., Dubey L., Steinberg S. P., Sherman D., Gershon M. D., Gershon A. A. 1989; Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation. Journal of Virology 63:4264–4276
    [Google Scholar]
12. Gong M., Ooka T., Matsuo T., Kieff E. 1987; Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. Journal of Virology 61:499–508
    [Google Scholar]
13. Gretch D. R., Gehrz R. C., Stinski M. F. 1988; Characterization of a human cytomegalovirus glycoprotein complex (gel). Journal of General Virology 69:1205–1215
    [Google Scholar]
14. Harlow E., Lane D. 1988 Antibodies: A laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
15. Hope R. G., Palfreyman J., Suh M., Mardsen H. S. 1982; Sulphated glycoproteins induced by herpes simplex virus. Journal of General Virology 58:399–415
    [Google Scholar]
16. Houghten R. A. 1987; Facile determination of exact amino acid involvement in peptide antigen-monoclonal antibody interactions. In Vaccines ′87 pp 1–6 Chanock R., Lerner R., Brown F., Ginsberg H. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
17. Kari B., Lussenhop N., Goertz R., Wabuke-Bunoti M., Radeke R., Gehrz R. 1986; Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. Journal of Virology 60:345–352
    [Google Scholar]
18. Kornfeld R., Kornfeld S. 1985; Assembly of asparagine-linked oligosaccharides. Annual Review of Biochemistry 54:631–664
    [Google Scholar]
19. Kyte J., Doolittle R. F. 1982; A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157:105–132
    [Google Scholar]
20. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
21. Lehner R., Meyer H., Mach M. 1989; Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses. Journal of Virology 63:3792–3800
    [Google Scholar]
22. Mach M., Utz U., Fleckenstein B. 1986; Mapping of the major glycoprotein gene of human cytomegalovirus. Journal of General Virology 67:1461–1467
    [Google Scholar]
23. Mach M., Stamminger T., Jahn G. 1989; Human cytomegalovirus: recent aspects from molecular biology. Journal of General Virology 70:3117–3146
    [Google Scholar]
24. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
25. Masuho Y., Matsumoto Y.-I., Sugano T., Fujinaga S., Minamishima Y. 1987; Human monoclonal antibodies neutralizing human cytomegalovirus. Journal of General Virology 68:1457–1461
    [Google Scholar]
26. Mirolo G., Baldassarri B., Ripalti A., Re M. C., Clementi M., Manzin A., Landini M. P. 1987; Antibody response to individual cytomegalovirus structural proteins in different groups of subjects. European Journal of Clinical Microbiology 6:207–210
    [Google Scholar]
27. Montalvo E. A., Grose C. 1987; Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpll(140). Journal of Virology 61:2877–2884
    [Google Scholar]
28. Pereira. L., Hoffman. M., Tatsuno. M., Dondero. D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. irology 139:73–86
    [Google Scholar]
29. Pereira L., Ali M., Kousoulas K., Huo B., Banks T. 1989; Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172:11–24
    [Google Scholar]
30. Perlman D., Halvorson H. O. 1983; A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides. Journal of Molecular Biology 167:391–409
    [Google Scholar]
31. Rasmussen L., Mullenax J., Nelson R., Merigan T. 1985; Viral polypeptides detected by complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. Journal of Virology 55:274–280
    [Google Scholar]
32. Rasmussen L., Nelson M., Neff M., Merigan T. 1988; Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody. Virology 163:308–318
    [Google Scholar]
33. Schoofs P. G., Geysen H. M., Jackson D. C., Brown L. E., Tang X.-L., White D. O. 1988; Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution. Journal of Immunology 140:611–616
    [Google Scholar]
34. Snydman D. R., Werner B. G., Heinze-Lacey B. 1987; Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. New England Journal of Medicine 317:1049–1054
    [Google Scholar]
35. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. 1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
    [Google Scholar]
36. Spear P. 1985; Glycoproteins specified by herpes simplex viruses. In The Herpesviruses 3 pp 315–356 Roizman B. Edited by London: Plenum Press;
    [Google Scholar]
37. Stannard L. M., Rider J. R., Farrar G. H. 1989; Morphology and distribution of gp52 on extracellular human cytomegalovirus (HCMV) supports biochemical evidence that it represents the HCMV glycoprotein B. Journal of General Virology 70:1553–1560
    [Google Scholar]
38. Utz U., Britt W., Vugler L., Mach M. 1989; Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63:1995–2001
    [Google Scholar]
39. WuDunn D., Spear P. G. 1989; Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. Journal of Virology 63:52–58
    [Google Scholar]